Short answer
Paysign, Inc. (PAYS) filed an 8-K current report with the SEC on November 9, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Paysign announced financial results for Q3 2026, ended September 30, 2026.
Paysign, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Paysign announced financial results for Q3 2026, ended September 30, 2026
- Exhibit 99.1 contains the earnings release and key financial details for investor review
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $30.8M, up 42.6%, led by pharma revenue doubling to $16.62M
- Gross margin rose to 64.7% from 56.3%, while operating margin more than tripled to 23.8%
- GAAP net income $6.74M, or $0.11 diluted EPS, up from $2.22M and $0.04
- Plasma customer transition of 113 centers could reduce Q4 revenue $1.5M and gross profit $700K
- 2026 revenue outlook maintained at $114.0M-$117.0M, with raised profitability guidance and $34.54M unrestricted cash, zero bank debt
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Paysign, Inc. 8-K filings
Get the next PAYS 8-K as it lands
Follow PAYS for push alerts, or ask the research agent what this filing means.